2015 Jul Cleave Biosciences Granted Key U.S. Patent Covering CB-5083 jadvargas2019-07-25T13:28:43-07:00July 30th, 2015| Read More
2015 Jul Cleave Biosciences Receives Orphan Designation from FDA for CB-5083 for Treatment of Multiple Myeloma admin2019-07-25T13:29:04-07:00July 13th, 2015| Read More
